Hero N° 02 sits inside the dessert category — one of sixteen launches in a portfolio built around modern science layered onto inherited ritual.
Each hero in the portfolio is a deliberate bet on a specific consumer shift: away from default Western formats, toward functional, ingredient-honest products with provable mechanisms. This page is the public-facing brief. The full thesis — formulation, unit economics, supply chain, founder background — lives behind the deal-room door.
Indulgence and guilt are no longer a fair trade. The post-Ozempic consumer wants the ritual of dessert without the metabolic punishment.
The 9pm wind-down. The Sunday-afternoon treat. The dessert occasion has not gone away — only the willingness to pay a sugar tax for it.
Better-for-you frozen and indulgent categories are the only growth pockets left in legacy ice-cream — and incumbents have no credible answer.
Households that already buy two SKUs of premium ice cream and want a third that doesn't undo their week.
We do not invent rituals. We replace the product inside one. Each hero in the portfolio sits on a specific, repeatable moment in the consumer's day — one the incumbent has owned for a generation and is now losing.
01
21:00
The wind-down
The dessert occasion is no longer about excess — it is about reward without regret. The brand that wins this slot replaces a habit, not a SKU.
02
Sun · 15:00
The shared treat
The Sunday-afternoon dessert is the most defensible household occasion. Frequency is locked in; the only question is which SKU sits in the freezer.
03
Post-meal
The course-closer
The dinner-party finale is where premium pricing earns out. A $12 pint that closes a $200 meal is rational, not extravagant.
The incumbent shelf
- —Häagen-Dazs
- —Ben & Jerry's
- —Talenti
- —Mass-market 'low-cal' brands
The new wave
- +Allulose-based premium
- +Heritage-spice frozen
- +Single-origin chocolate frozen
- +Ayurvedic dessert formats
"The dessert aisle is the last category in grocery where a credible new entrant can take 5% share in 24 months."
$98B global ice cream and frozen dessert market, $24B in 'better-for-you' segment.
Halo Top sold to Wells Enterprises for ~$2B. Van Leeuwen raised at a $400M valuation. Both built on novelty bases. Ours is built on a 3,000-year-old metabolic playbook.
The product specifics — the proprietary formulation, the brand architecture, the channel strategy, the unit economics — are deliberately not on this page. We don't publish the recipe to the open internet.
- Full formulation & ingredient stack
- Clinical and mechanism-of-action references
- Founder thesis and category positioning
- Unit economics and pricing model
- Supply chain and manufacturing partner
- Go-to-market plan and channel mix
- Isn't this category crowded?
- Crowded with low-cal compromise. Empty in the 'premium and metabolically honest' quadrant — which is where the spending consumer actually lives.
- How does this work in a GLP-1 world?
- GLP-1 users eat less, not nothing — and they spend disproportionately on small, high-quality indulgences. Smaller portions, higher prices, premium formats win.
- Is this a fad?
- Sugar reformulation is a generational shift, not a fad. The behavioural change is downstream of pharmacology, not marketing.
The next move.
The investor deck, unit economics, and a direct line to the founder live behind the deal-room door. Or stay close to the portfolio with a monthly subscriber drop — first look on every new SKU.
